Iliac artery revascularization: Overview of current interventional therapies

Interventional Cardiology

Volumn 2, Issue 6, 2010, Pages 851-859

  Lam, Cuong ^a   Gandhi, Ripal T ^b   Vatakencherry, Geogy ^a   Katzen, Barry T ^b  

^a KAISER PERMANENTE MEDICAL CENTER   (United States)

^b BAPTIST CARDIAC AND VASCULAR INSTITUTE   (United States)

Author keywords

balloon expandable stent; covered stent; iliac occlusive disease; percutaneous transluminal angioplasty; self expanding stent

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; CLOPIDOGREL; HEPARIN; NITINOL; POLITEF; POLYETHYLENE TEREPHTHALATE;

ANTICOAGULANT THERAPY; ATHEROSCLEROSIS; BALLOON CATHETER; BALLOON EXPANDABLE STENT; BARE METAL STENT; CLINICAL TRIAL; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DOPPLER ECHOGRAPHY; DRUG DELIVERY SYSTEM; ENDOPROSTHESIS; HEART DEATH; HEART INFARCTION; HUMAN; ILIAC ARTERY OBSTRUCTION; ILIAC ARTERY REVASCULARIZATION; IMPLANTATION; IN-STENT RESTENOSIS; INTERVENTION STUDY; LEG REVASCULARIZATION; LIMB ISCHEMIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SAFETY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POLITEF IMPLANT; POSTOPERATIVE THROMBOSIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; REVIEW; SELF EXPANDING STENT; STENT; TREATMENT OUTCOME; VASCULAR ACCESS DEVICE; VASCULAR PATENCY;

EID: 78650260905     PISSN: 17555302     EISSN: 17555310     Source Type: Journal    
DOI: 10.2217/ica.10.89     Document Type: Review

References (35)

1. Selvin E, Erlinger TP: Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 110(6), 738-743 (2004).
2. Hirsch AT, Criqui MH, Treat-Jacobson D et al.: Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 286(11), 1317-1324 (2001).
3. Norgren L, Hiatt WR, Dormandy JA et al.: Inter-society consensus for the management of peripheral arterial disease (TASC II). J. Vasc. Surg. 45(Suppl. S), S5 (2007).
4. Faries P, Morrissey NJ, Teodorescu V et al.: Recent advances in peripheral angioplasty and stenting. Angiology 59, 617-626 (2002).
5. Rosanio S, Tocchi M, Uretsky BF, Stouffer GA: Use of intraluminal stents in the treatment of carotid, renal, and peripheral arterial disease. Am. J. Med. Sci. 319, 111-117 (2000).
6. Hood DB, Hodgson KJ: Percutaneous transluminal angioplasty and stenting for iliac artery occlusive disease. Surg. Clin. North Am. 79, 575-596 (1999).
7. Martin EC, Katzen BT, Benenati JF et al.: Multicenter trial of the Wallstent in the iliac and femoral arteries. J. Vasc. Interv. Radiol. 6, 843-849 (1995).
8. Henry M, Amor M, Beyar R et al.: Clinical experience with a new nitinol self-expanding stent in peripheral arteries. J. Endovasc. Surg 3, 369-379 (1996).
9. Vorwerk D, Günther RW, Schürmann K, Wendt G: Aortic and iliac stenoses: follow-up results of stent placement after insuffcient balloon angioplasty in 118 cases. Radiology 198, 45-48 (1996).
10. Henry M, Amor M, Ethevenot G, Henry I, Mentre B, Tzvetanov K: Percutaneous endoluminal treatment of iliac occlusions: long-term follow-up in 105 patients. J. Endovasc. Surg. 5, 228-235 (1998).
11. Hassen-Khodja R, Sala F, Declemy S et al.: Value of stent placement during percutaneous transluminal angioplasty of the iliac arteries. J. Cardiovasc. Surg. 42, 369-374 (2001).
12. Bosch JL, Hunink MGM: Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease. Radiology 204, 87-96 (1997).
13. Sullivan TM, Childs MB, Bacharach JM et al.: Percutaneous transluminal angioplasty and primary stenting of the iliac arteries in 288 patients. J. Vasc. Surg. 25, 829-838 (1997).
14. Ansel GM, Kazienko BT, Lipman JC et al.: Long-term and secondary patency of iliac arterial Wallstenting followed with ongoing limb surveillance. Am. J. Cardiol. 88(Suppl. 5A), G29 (2001).
15. Murphy TP, Webb MS, Lambiase RE et al.: Percutaneous revascularization of complex iliac artery stenoses and occlusions with use of Wallstents: 3-year experience. J. Vasc. Interv. Radiol. 7, 21-27 (1996).
16. Ballard JL, Bergan JJ, Singh P et al.: Aortoiliac stent deployment versus surgical reconstruction: analysis of outcome and cost. J. Vasc. Surg. 28, 94-101 (1998).
17. Treiman GS, Schneider PA, Lawrence PF et al.: Does stent placement improve the results of ineffective or complicated iliac artery angioplasty? J. Vasc. Surg. 28, 104-112, discussion 113-114 (1998).
18. Richter GM, Roeren T, Noeldge G et al.: Initial long-term results of a randomized 5 year study: iliac stent implantation versus PTA. VASA (Suppl.) 35, 192-193 (1992).
19. Rzucidlo EM, Powell RJ, Zwolak RM: Early results of stent-grafting to treat diffuse aortoiliac occlusive disease. J. Vasc. Surg. 37, 1175-1180 (2003).
20. Powell RJ, Fillinger M, Walsh DB et al.: Predicting outcome of angioplasty and selective stenting of multisegment iliac artery occlusive disease. J. Vasc. Surg. 32, 564-569 (2000).
21. Vorwerk D, Guenther RW, Shurmann K et al.: Primary stent placement for chronic iliac artery occlusions: follow-up results in 103 patients. Radiology 194, 745-749 (1995).
22. Henry M, Amor M, Ethevenot G et al.: Percutaneous endoluminal treatment of iliac occlusions: long-term follow-up in 105 patients. J. Endovasc. Surg. 5, 228-235 (1998).
23. Uher P, Nyman U, Lindh M et al.: Long-term results of stenting for chronic iliac artery occlusion. J. Endovasc. Ther. 9, 67-75 (2002).
24. Tetteroo E, van der Graaf Y, Bosch JL et al.: Randomised comparison of primary stent placement versus primary angioplasty followed by selective stent placement in patients with iliac-artery occlusive disease. Dutch Iliac Stent Trial Study Group. Lancet 35, 1153-1159 (1998).
25. Klein WM, van der Graaf Y, Seeger J et al.: Long-term cardiovascular morbidity, mortality, and reintervention after endovascular treatment in patients with iliac artery disease: the Dutch Iliac Stent Trial study Radiology 232, 491-498 (2004).
26. Haulon S, Mounier-Vehier C, Gaxotte V et al.: Percutaneous reconstruction of the aortoiliac bifurcation with the 'kissing stents' technique: long-term follow-up in 106 patients. J. Endovasc. Ther. 9, 363-368 (2002).
27. Stockx L, Poncyljusz W, Falkowski A et al.: Express™ vascular LD stent in the treatment of iliac artery lesions: 24-month results from the MELODIE trial; Cardiovasc. Inter. Rad. 30(1), 282 (2007).
28. Palmaz J, Laborde J, Rivera F et al.: Stenting of the iliac arteries with the Palmaz stent: experience from a multicenter trial. Cardiovasc. Interv. Radiol. 15, 291-297 (1992).
29. Murphy KD, Encarnacion CE, Le VA et al.: Iliac artery stent placement with the Palmaz stent: follow-up study J. Vasc. Interv. Radiol. 6, 321-329 (1995).
30. Ponec D, Jaff MR, Swischuk J: The nitinol SMART stent versus Wallstent for suboptimal iliac artery angioplasty: CRISP-US trial results J. Vasc. Interv. Radiol. 15, 911-918 (2004).
31. Krol KL, Saxon RR, Farhat N et al.: Clinical evaluation of the Zilver vascular stent for symptomatic iliac artery disease. J. Vasc. Interv. Radiol. 19, 15-22 (2008).
32. Jaff MR, Katzen BT: 2 year clinical evaluation of the Zilver vascular stent for symptomatic iliac artery disease. J. Vasc. Interv. Radiol. 21, 1489-1494 (2010).
33. Ansel GM: Endoprosthesis in complex iliac stenosis and occlusion: results of the prospective, multicenter randomized trial. Curr. Interv. Cardiol. Rep. 1, 303-309 (1999).
34. Lammer J, Dake MD, Bleyn J et al.: Peripheral arterial obstruction: prospective study of treatment with a transluminally placed self-expanding stent graft. Radiology 217, 95-104 (2000).
35. Mwipatayi P: Covered balloon-expandable versus bare metal stents for complex iliac disease-fnal results of the COBEST-Study Presented at: The Leipzig Interventional Course 2010. Leipzig, Germany, 27-30 January 2010.